Dupont Capital Management Corp Dynavax Technologies Corp Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021
SELL
$7.25 - $10.99 $436,152 - $661,147
-60,159 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$4.57 - $11.18 $340,981 - $834,173
-74,613 Reduced 55.36%
60,159 $591,000
Q4 2020

Jan 28, 2021
BUY
$3.73 - $5.6 $328,396 - $493,035
88,042 Added 188.41%
134,772 $600,000
Q3 2020

Oct 29, 2020
BUY
$4.32 - $11.7 $201,873 - $546,741
46,730 New
46,730 $202,000

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email